2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide

C76H94F4N12O4 — CID 160808730

IUPAC2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide
SMILESCC(=O)Nc1ncc(-c2ccc(F)cc2)nc1CC(C)C.CC(C)CC(=O)Nc1ncc(-c2ccc(F)cc2)nc1CC(C)C.CC(C)Cc1nc(-c2ccc(F)cc2)cnc1NC(=O)CC1CCCCC1.CCC(C)C(=O)Nc1ncc(-c2ccc(F)cc2)nc1CC(C)C
InChIInChI=1S/C22H28FN3O.2C19H24FN3O.C16H18FN3O/c1-15(2)12-19-22(26-21(27)13-16-6-4-3-5-7-16)24-14-20(25-19)17-8-10-18(23)11-9-17;1-12(2)9-16-19(23-18(24)10-13(3)4)21-11-17(22-16)14-5-7-15(20)8-6-14;1-5-13(4)19(24)23-18-16(10-12(2)3)22-17(11-21-18)14-6-8-15(20)9-7-14;1-10(2)8-14-16(19-11(3)21)18-9-15(20-14)12-4-6-13(17)7-5-12/h8-11,14-16H,3-7,12-13H2,1-2H3,(H,24,26,27);5-8,11-13H,9-10H2,1-4H3,(H,21,23,24);6-9,11-13H,5,10H2,1-4H3,(H,21,23,24);4-7,9-10H,8H2,1-3H3,(H,18,19,21)
InChIKeySEAQPUNXOXXNFL-UHFFFAOYSA-N
MW1315.66 g/mol
LogP17.76
Rot. Bonds22

About 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide

2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide (PubChem CID 160808730) has the molecular formula C76H94F4N12O4 and a molecular weight of 1315.66 g/mol. Its IUPAC name is 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide.

Molecular Properties

Compound Name2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide
PubChem CID160808730
Molecular FormulaC76H94F4N12O4
Molecular Weight1315.66 g/mol
Exact Mass1314.75
IUPAC Name2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide
SMILESCC(=O)Nc1ncc(-c2ccc(F)cc2)nc1CC(C)C.CC(C)CC(=O)Nc1ncc(-c2ccc(F)cc2)nc1CC(C)C.CC(C)Cc1nc(-c2ccc(F)cc2)cnc1NC(=O)CC1CCCCC1.CCC(C)C(=O)Nc1ncc(-c2ccc(F)cc2)nc1CC(C)C
InChIInChI=1S/C22H28FN3O.2C19H24FN3O.C16H18FN3O/c1-15(2)12-19-22(26-21(27)13-16-6-4-3-5-7-16)24-14-20(25-19)17-8-10-18(23)11-9-17;1-12(2)9-16-19(23-18(24)10-13(3)4)21-11-17(22-16)14-5-7-15(20)8-6-14;1-5-13(4)19(24)23-18-16(10-12(2)3)22-17(11-21-18)14-6-8-15(20)9-7-14;1-10(2)8-14-16(19-11(3)21)18-9-15(20-14)12-4-6-13(17)7-5-12/h8-11,14-16H,3-7,12-13H2,1-2H3,(H,24,26,27);5-8,11-13H,9-10H2,1-4H3,(H,21,23,24);6-9,11-13H,5,10H2,1-4H3,(H,21,23,24);4-7,9-10H,8H2,1-3H3,(H,18,19,21)
InChIKeySEAQPUNXOXXNFL-UHFFFAOYSA-N
XLogP17.76
TPSA219.52 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds22
Heavy Atoms96
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001315.66
LogP ≤ 517.76
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Analyze 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide?
The IUPAC name of 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide (CID 160808730) is 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide.
What is the SMILES notation for 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide?
The canonical SMILES for 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide is CC(=O)Nc1ncc(-c2ccc(F)cc2)nc1CC(C)C.CC(C)CC(=O)Nc1ncc(-c2ccc(F)cc2)nc1CC(C)C.CC(C)Cc1nc(-c2ccc(F)cc2)cnc1NC(=O)CC1CCCCC1.CCC(C)C(=O)Nc1ncc(-c2ccc(F)cc2)nc1CC(C)C.
What is the InChIKey of 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide?
The InChIKey is SEAQPUNXOXXNFL-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H28FN3O.2C19H24FN3O.C16H18FN3O/c1-15(2)12-19-22(26-21(27)13-16-6-4-3-5-7-16)24-14-20(25-19)17-8-10-18(23)11-9-17;1-12(2)9-16-19(23-18(24)10-13(3)4)21-11-17(22-16)14-5-7-15(20)8-6-14;1-5-13(4)19(24)23-18-16(10-12(2)3)22-17(11-21-18)14-6-8-15(20)9-7-14;1-10(2)8-14-16(19-11(3)21)18-9-15(20-14)12-4-6-13(17)7-5-12/h8-11,14-16H,3-7,12-13H2,1-2H3,(H,24,26,27);5-8,11-13H,9-10H2,1-4H3,(H,21,23,24);6-9,11-13H,5,10H2,1-4H3,(H,21,23,24);4-7,9-10H,8H2,1-3H3,(H,18,19,21).
What are the key properties of 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide?
2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide has a molecular weight of 1315.66 g/mol, XLogP of 17.76, 22 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclohexyl-N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]acetamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-2-methylbutanamide;N-[5-(4-fluorophenyl)-3-(2-methylpropyl)pyrazin-2-yl]-3-methylbutanamide is sourced from PubChem (CID 160808730), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).